How Are National Viral Research and Diagnostic Laboratories Protecting India from Viruses and Pathogens?

Synopsis
Key Takeaways
- VRDLs are essential for public health safety.
- They enhance India's pandemic preparedness.
- New initiatives aim to streamline diagnostic processes.
- Bio-Safety Level 3 facilities are crucial for research.
- Real-time tracking of infections supports effective resource allocation.
New Delhi, Sep 11 (NationPress) The 164 National Viral Research and Diagnostic Laboratories (VRDLs) serve as vigilant protectors against viruses and pathogens, asserted Anupriya Patel, the Union Minister of State for Health, during a speech on Thursday.
While addressing the National VRDL Conclave 2025 in New Delhi, Patel emphasized that pandemic preparedness and VRDLs are integral components of a broader national framework focused on health research and innovation.
“Our VRDLs have acted as guardians during the Covid-19 pandemic and beyond. The emphasis is on detecting emerging bacteria, viruses, and pathogens, as well as on India's advancements in diagnostics,” Patel remarked.
The MoS recognized the substantial contributions of these laboratories in sequencing the virus and validating nearly 1,700 diagnostic tools.
“VRDLs have been crucial for the early identification of outbreaks such as Nipah, Zika, and Kyasanur Forest Disease,” Patel noted, highlighting that 16 of these laboratories are now equipped with Bio-Safety Level 3 facilities for researching high-risk pathogens.
The Union Minister also inaugurated the In-Vitro Diagnostics (IVD) validation portal and its protocols, expressing optimism that “the newly launched IVD validation portal will enable quicker, more transparent, and industry-friendly validation processes.”
In an effort to bolster evidence-based policymaking, Patel unveiled the first VRDL Bulletin, stating that “this will facilitate real-time monitoring of viral infections to enhance resource distribution by both state and central governments.”
Additionally, Dr. Rajiv Bahl, Director General of ICMR, mentioned that the two-day conclave will reveal groundbreaking initiatives aimed at fortifying the nation’s capability to respond adeptly to viral outbreaks, emerging infections, and other health emergencies, while reinforcing the vision of Atmanirbhar Bharat.
“Just as India’s air defense was impenetrable during the recent Operation Sindoor, the VRDL network will serve as an unassailable biodefense for India,” he asserted.
“With 164 laboratories across 26 states and 5 Union Territories, the VRDL network is a crucial safeguard that enables early detection, swift diagnosis, and prompt response to infectious diseases. Its remarkable contributions during emergencies such as the COVID-19 pandemic, and outbreaks like Nipah, Kyasanur Forest Disease, Zika, and Crimean-Congo Hemorrhagic Fever, have significantly enhanced India’s disease surveillance and emergency response capabilities,” he added.